Breast Cancer Awareness Month: New insights to guide survivorship care
Click Here to Manage Email Alerts
Breast Cancer Awareness Month is observed every October.
In conjunction with this observance, Healio provides the following updates in breast cancer treatment and survivorship.
1. Neoadjuvant durvalumab (Imfinzi, AstraZeneca) plus chemotherapy conferred comparable benefit to women with triple-negative breast cancer regardless of race. Read more.
2. Although most women with breast cancer reported adverse sexual health effects of treatment, many expressed a desire for more information and resources on this topic during treatment. Read more.
3. Black women with advanced-stage hormone receptor-positive breast cancer experienced poor response to treatment with neoadjuvant endocrine therapy compared with white women with similar disease presentation. Read more.
4. More than one in seven breast cancer survivors reported persistent financial hardship within 5 years of diagnosis, according to study results. Read more.
5. One-third of young breast cancer survivors experienced significant weight gain at 3 years after diagnosis, and financial comfort appeared associated with risk. Read more.
6. The addition of abemaciclib (Verzenio, Eli Lilly) to a nonsteroidal aromatase inhibitor prolonged median OS by more than a year among patients with hormone receptor-positive, HER2-negative advanced breast cancer. Read more.
7. Longer time to therapy initiation appeared associated with poorer adherence to adjuvant endocrine therapy among Medicaid-insured women diagnosed with primary hormone receptor-positive breast cancer. Read more.
8. Fewer than half of breast cancer studies in the National Cancer Database reported Hispanic ethnicity, and about one-third categorized race and ethnicity into mutually exclusive groups. Read more.
9. Physicians may overlook substantial symptoms among certain patients undergoing radiotherapy for breast cancer, especially those who are young, Black or of “other” race or ethnicity. Read more.
10. Cancer-related fatigue appeared associated with greater postural sway among a cohort of breast cancer survivors. Read more.
Collapse
Healio Coverage
Click Here to Manage Email Alerts